Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
Recent NAFDAC actions signal a stronger enforcement posture on drug and product safety, including blacklisting a foreign supplier and watchlisting a local marketer, alongside capacity-building initiatives like a pharmacist reserve group and mandatory clinical trial training. For Nigerian SMBs in pharmaceuticals, healthcare, and related distribution, this means heightened scrutiny and the need to verify supply chain partners and maintain compliance. The CBN's Bureau De Change guidelines also affect financial services SMBs, requiring adherence to updated operational rules.
Pharmaceuticals and Healthcare
Importation and Distribution
Financial Services (Bureau De Change)
Agriculture and Export (Fish Farming)
Regulatory Compliance
NAFDAC Blacklists Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC has blacklisted Ayrtons Saunders Ltd, UK, prohibiting the importation, distribution, and sale of its products in Nigeria.
SMBs importing or distributing Ayrtons Saunders products must immediately cease and verify no stock remains; failure could lead to regulatory penalties.
NAFDAC Places Mofus Nigeria Ltd Products on Watchlist
NAFDAC
NAFDAC has placed products marketed by Mofus Nigeria Ltd on a watchlist pending regulatory investigation, urging stakeholders to report adverse effects.
Retailers, distributors, and PPMVs should quarantine Mofus products and await further directives; continued sale may attract sanctions.
NAFDAC and NHREC Announce New Dates for Mandatory Clinical Trial Regulations Training
NAFDAC
NAFDAC and NHREC have rescheduled mandatory stakeholder training on clinical trial regulations in Nigeria.
SMBs involved in clinical trials or research must ensure key personnel attend the training to remain compliant with regulatory requirements.
Inauguration of NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated a Pharmacist Reserve Group of 600 pharmacists to provide voluntary service, enhancing regulatory capacity.
Pharmacies and pharmaceutical SMBs may benefit from increased regulatory support and faster service delivery, but should also prepare for more rigorous oversight.
Address by NAFDAC DG at Chemical Society of Nigeria Conference
NAFDAC
NAFDAC DG highlighted innovations in medicinal and pharmaceutical chemistry for affordable healthcare delivery.
SMBs in pharmaceutical manufacturing and research should align with NAFDAC's focus on innovation and quality to leverage potential partnerships and funding.
Regulatory and Supervisory Guidelines for Bureau De Change Operations in Nigeria 2024
CBN
The CBN issued updated regulatory and supervisory guidelines for Bureau De Change operations in Nigeria.
SMBs operating as BDCs must comply with new capital, reporting, and operational requirements to avoid penalties or license revocation.
NDLEA, NAFDAC Exempted from Dissolution of FG Parastatals Boards
NAFDAC
NDLEA and NAFDAC were exempted from the dissolution of boards of federal government parastatals, ensuring continuity.
SMBs regulated by NAFDAC can expect stability in leadership and ongoing regulatory initiatives, reducing uncertainty.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
NEPC
A guide on registering fish farms with NEPC for export purposes.
SMBs in fish farming and export should follow the guide to access export incentives and meet international standards.
Increased NAFDAC enforcement on product safety and supply chain integrity.
Mandatory training for clinical trial stakeholders indicates tighter regulation in research.
CBN's BDC guidelines may lead to consolidation and higher compliance costs for small operators.
NAFDAC's pharmacist reserve group could improve regulatory responsiveness but also signal more inspections.
Export opportunities for fish farmers through NEPC registration.
1
Immediately verify and remove any Ayrtons Saunders Ltd products from inventory and supply chains.
2
Quarantine all products from Mofus Nigeria Ltd and await NAFDAC's investigation outcome.
3
Register for the NAFDAC/NHREC mandatory clinical trial regulations training if involved in clinical research.
4
Review and update BDC operations to align with CBN's 2024 guidelines, including capital and reporting requirements.
5
For fish farmers, initiate NEPC registration to access export markets and comply with export regulations.
6
Stay updated with NAFDAC public alerts and watchlists to avoid distributing non-compliant products.